InvestorsHub Logo
icon url

Enterprising Investor

02/09/15 9:42 AM

#53 RE: fredman #52

Possible.

Since the first CVR payment of $3.50 will most likely occur in Q2 or probably no later than early Q3, now may just be the right time.

I could envision a tender offer coming in below the $6.50 maximum payout, somewhere between $5.00 and $5.25 per CVR.
icon url

fredman

02/10/15 10:13 AM

#58 RE: fredman #52

WMGIZ CVR buyback is a good possibility, imo.

$533 million proceeds
- $51 million transaction expenses
- $292 million notes repurchase
Balance = $190 million

Total WMGIZ CVR value @ $6.50 = $190 million




"The Company estimates that the net proceeds of the offering will be approximately $533 million (or $613 million if the initial purchasers exercise their over-allotment option in full), after deducting the initial purchasers' discounts and commissions and estimated offering expenses. The Company expects to use approximately $51 million of the net proceeds from the offering (or $58 million if the initial purchasers exercise their over-allotment option in full) to pay the cost of the cash convertible note hedge transactions (after such cost is partially offset by the proceeds to the Company from the sale of the warrants). The Company also expects to use approximately $292 million of the net proceeds of the offering to repurchase approximately $240 million aggregate principal amount of the Company's outstanding 2.00% cash convertible senior notes due 2017 in privately negotiated transactions and the remaining net proceeds from the offering for general corporate purposes, including possible acquisitions."

Source: http://www.marketwatch.com/story/wright-medical-group-inc-prices-550-million-cash-convertible-senior-notes-offering-2015-02-10